Errol Gould

1.0k total citations
47 papers, 755 citations indexed

About

Errol Gould is a scholar working on Pharmacology, Physiology and Anesthesiology and Pain Medicine. According to data from OpenAlex, Errol Gould has authored 47 papers receiving a total of 755 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pharmacology, 15 papers in Physiology and 13 papers in Anesthesiology and Pain Medicine. Recurrent topics in Errol Gould's work include Musculoskeletal pain and rehabilitation (14 papers), Pain Mechanisms and Treatments (14 papers) and Pain Management and Opioid Use (10 papers). Errol Gould is often cited by papers focused on Musculoskeletal pain and rehabilitation (14 papers), Pain Mechanisms and Treatments (14 papers) and Pain Management and Opioid Use (10 papers). Errol Gould collaborates with scholars based in United States, Canada and Japan. Errol Gould's co-authors include Arnold R. Gammaitoni, Mark P. Jensen, Timothy W. Victor, Bradley S. Galer, Richard E. White, Susan Potts, Qinfang Xiang, Christopher M. Rembold, Richard A. Murphy and Beverly A. Jones and has published in prestigious journals such as Journal of the American College of Cardiology, Brain Research and Pain.

In The Last Decade

Errol Gould

45 papers receiving 713 citations

Peers

Errol Gould

PHARM

PHYSI

EDM

SURGE

Harry L. Hébert United Kingdom

Ole Eshøj Denmark

Bernhard Frank United Kingdom

Dominique Lossignol Belgium

César Margarit Spain

L. Pauer United States

Saiying Wang China

Chantal Touboul France

Marina Brodsky United States

David W. Boorman United States

Harry L. Hébert United Kingdom

Errol Gould

118 ×0.5

PHARM

365 ×1.9

PHYSI

97 ×0.6

76 ×0.6

EDM

46 ×0.4

SURGE

Citations per year, relative to Errol Gould Errol Gould (= 1×) peers Harry L. Hébert

Countries citing papers authored by Errol Gould

Since Specialization

Citations

This map shows the geographic impact of Errol Gould's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Errol Gould with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Errol Gould more than expected).

Fields of papers citing papers by Errol Gould

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Errol Gould. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Errol Gould. The network helps show where Errol Gould may publish in the future.

Co-authorship network of co-authors of Errol Gould

This figure shows the co-authorship network connecting the top 25 collaborators of Errol Gould. A scholar is included among the top collaborators of Errol Gould based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Errol Gould. Errol Gould is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pergolizzi, Joseph V., et al.. (2024). A Single Ascending-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel Respiratory Stimulant ENA-001. Cureus. 16(2). e55057–e55057. 1 indexed citations

Chang, Ellen T., et al.. (2022). Use of Contrave, Naltrexone with Bupropion, Bupropion, or Naltrexone and Major Adverse Cardiovascular Events: A Systematic Literature Review. Diabetes Metabolic Syndrome and Obesity. Volume 15. 3049–3067. 6 indexed citations

McIntyre, Roger S., et al.. (2021). Psychiatric Safety and Weight Loss Efficacy of Naltrexone/bupropion as Add-on to Antidepressant Therapy in Patients with Obesity or Overweight. Journal of Affective Disorders. 289. 167–176. 15 indexed citations

Wharton, Sean, Peter Yin, Melonie Burrows, et al.. (2021). Extended-release naltrexone/bupropion is safe and effective among subjects with type 2 diabetes already taking incretin agents: a post-hoc analysis of the LIGHT trial. International Journal of Obesity. 45(8). 1687–1695. 7 indexed citations

Nalamachu, Srinivas, et al.. (2015). An Analysis of Rescue Medication Utilization from a 3-Month, Randomized, Double-Blind, Placebo-Controlled Study in Patients with Chronic Low Back Pain Treated with Single-Entity, Twice-Daily, Extended-Release Hydrocodone. Pain Medicine. 16(12). 2338–2343. 1 indexed citations

Morgentaler, Abraham, et al.. (2014). Pharmacokinetics and drying time of testosterone 2% gel in men with hypogonadism: a multicenter, open-label, single-arm trial. International Journal of Impotence Research. 27(2). 41–45. 4 indexed citations

Jensen, Mark P., Xiaojun Hu, Susan Potts, & Errol Gould. (2012). Single vs composite measures of pain intensity: Relative sensitivity for detecting treatment effects. Pain. 154(4). 534–538. 36 indexed citations

Dworkin, Robert H., Mark P. Jensen, Errol Gould, et al.. (2010). Treatment Satisfaction in Osteoarthritis and Chronic Low Back Pain: The Role of Pain, Physical and Emotional Functioning, Sleep, and Adverse Events. Journal of Pain. 12(4). 416–424. 50 indexed citations

Xiang, Qinfang, et al.. (2010). Factors affecting acceptability of titrated oxymorphone extended release in chronic low back pain – an individual patient analysis. Current Medical Research and Opinion. 26(8). 1861–1871. 4 indexed citations

10.

Harden, R. Norman, Christine Gagnon, Joseph R. Graciosa, & Errol Gould. (2010). Negligible Analgesic Tolerance Seen with Extended Release Oxymorphone: APost HocAnalysis of Open-Label Longitudinal Data. Pain Medicine. 11(8). 1198–1208. 6 indexed citations

11.

Victor, Timothy W., Nancy A. Álvarez, & Errol Gould. (2009). Opioid Prescribing Practices in Chronic Pain Management: Guidelines Do Not Sufficiently Influence Clinical Practice. Journal of Pain. 10(10). 1051–1057. 30 indexed citations

12.

Pergolizzi, Joseph V., Robert B. Raffa, & Errol Gould. (2009). Considerations on the use of oxymorphone in geriatric patients. Expert Opinion on Drug Safety. 8(5). 603–613. 8 indexed citations

13.

Gould, Errol, et al.. (2009). Oxymorphone extended release for the treatment of chronic low back pain: A retrospective pooled analysis of enriched-enrollment clinical trial data stratified according to age, sex, and prior opioid use. Clinical Therapeutics. 31(2). 347–359. 21 indexed citations

14.

Kivitz, Alan, Eric Sheldon, Qinfang Xiang, et al.. (2008). Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clinical Therapeutics. 30(12). 2366–2377. 39 indexed citations

15.

Brunzell, John D., Santica Marcovina, Dahong Yu, et al.. (2004). 1124-192 Rosiglitazone reduces novel biomarkers of cardiovascular disease in subjects with type 2 diabetes mellitus already on statin therapy. Journal of the American College of Cardiology. 43(5). A504–A504. 4 indexed citations

16.

Gould, Errol, et al.. (2003). Rosiglitazone increases high-density lipoprotein cholesterol levels in patients with type 2 diabetes. Journal of the American College of Cardiology. 41(6). 316–316. 2 indexed citations

17.

Gómez‐Pérez, Francisco J., et al.. (2002). Efficacy and safety of rosiglitazone plus metformin in Mexicans with type 2 diabetes. Diabetes/Metabolism Research and Reviews. 18(2). 127–134. 87 indexed citations

18.

Gould, Errol, et al.. (2000). Graveyard gleanings: socio-economic, geographical and gender inequalities in health at Tynemouth, UK, 1833-1853. Journal of Public Health. 22(3). 280–286. 6 indexed citations

19.

Chen, Xiaoliang, et al.. (1996). Focal increases in [Ca2+]i may account for apparent low Ca2+ sensitivity in swine carotid artery. Cell Calcium. 19(6). 501–508. 5 indexed citations

20.

Gould, Errol, et al.. (1995). The role of GABAA receptors in the subsensitivity of Purkinje neurons to GABA in genetic epilepsy prone rats. Brain Research. 698(1-2). 62–68. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact